CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic peptide that stimulates the body’s own growth hormone (GH) release. The DAC allows the peptide to bind to albumin in the blood, extending its half-life to about 5-8 days. This results in sustained elevation of GH and IGF-1 levels with less frequent injections. It is commonly used to support muscle recovery, fat loss, sleep quality, and anti-aging effects. CJC-1295 with DAC is typically administered by subcutaneous injection once weekly. It is not approved for medical use and is classified as a research compound. Possible side effects include water retention, flushing, headache, and mild insulin resistance.
Dosing CJC-1295 (with DAC):
protocol presents a twice-weekly subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
• Reconstitute: Add 2.0 mL bacteriostatic water → 2.5 mg/mL (2500 mcg/mL) concentration.
• Typical dose range: 300-1000 mcg per injection, twice weekly (gradual titration).
• Easy measuring: At 2.5 mg/mL, 1 unit = 0.01 mL = 25 mcg on a U-100 insulin syringe.